Skip to main content
Contact Us
Subscribe
E-Edition
69°
Site search
Search
Menu
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
About Us
Contact Us
Advertise
Terms and Conditions
Privacy Policy
Home Delivery
Subscription Services
Place an Ad
Promote Your Event
Local Weather
News
Sports
Obits
Multimedia
Photo Galleries
Videos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Subscribe
Best of 2024
Archives
2025 Calendar Photos
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about NMLSF
Recent news which mentions NMLSF
Psyched: LSD For Major Depression, Canada's Psilocybin Macrodose Trial, Treatments For Multiple Sclerosis And More
April 24, 2023
Tickers
AWKNF
CMND
DRUG
HUGE
Tags
News
Psychedelics Reform
Markets
From
Benzinga
Psychedelics And The Spectrum: Groundbreaking Study Details How One Firm Approaches Autism
April 20, 2023
Tickers
NMLSF
Tags
Top Stories
Markets
Guidance
From
Benzinga
Psyched: Four New States With Reform Bills, Psilocybin For Genetic Disorders And Functional Neurological Disorder, Struggle For Access & More
February 21, 2023
Tickers
AGNPF
AWKNF
CYBN
DMTTF
Tags
FLHLF
NMLSF
KONEF
From
Benzinga
Health Canada Grants Exemption: Phase 2 Trial On Psilocybin For Genetic Disorder
February 14, 2023
Tickers
KONEF
NMLSF
Tags
Psilocybin Microdosing
Markets
NMLSF
From
Benzinga
First-Ever Clinical Trial On Magic Mushroom Therapy For Autism's Genetic Cause Receives Approval
December 27, 2022
Tickers
KONEF
NMLSF
Tags
Benzinga
Penny Stocks
Cannabis
From
Benzinga
Psyched: Fed Guidelines And Research Production Quotas, Protests In Canada, Cal's Decrim Project
December 06, 2022
Tickers
AWKNF
BRAXF
DEA
FLHLF
Tags
AWKNF
Psychedelics
DEA
From
Benzinga
Psychedelic Partnership To Test Psilocybin For FXS In First Phase 2 Clinical Trial
November 30, 2022
Tickers
KONEF
NMLSF
Tags
Benzinga
Penny Stocks
psilocybin therapies
From
Benzinga
Psychedelics For FXS Symptoms: New Research Contract For Upcoming Phase 2 Clinical Trial
November 17, 2022
Tickers
KONEF
NMLSF
Tags
Markets
NMLSF
Phase 2 Clinical Trial
From
Benzinga
Psyched: Autopsy Reveals Death By Ketamine, LSD-Like Drugs Without Hallucinations, DEA & Right To Try Psilocybin
September 30, 2022
Tickers
ATAI
BMNDF
NMLSF
Tags
ATAI
BMNDF
News
From
Benzinga
Magic Mushroom In A Pill? New Microdose Plans Enter Clinical Studies: Here's What Scientists Want To Learn
September 29, 2022
Tickers
NMLSF
Tags
Psychedelics
Psilocybin Microdosing
Markets
From
Benzinga
New Batch Of Psilocybin Microdose Capsules Is Ready, Learn All The Details
September 17, 2022
Tickers
NMLSF
Tags
Health Canada Approval
Market News
Cannabis
From
Benzinga
More Patent Applications For Psilocybin: Learn About NOVA's Psychedelic Treatments For Neurological Diseases
June 16, 2022
Tickers
NMLSF
Tags
Dr/ Marvin S/ Hausman
Psychedelics
Market News
From
Benzinga
Psyched: Christie's Launches NFT Collection Supporting Psychedelic Science, Origin's Listing On CSE Gives Retail Investors Access To Private Companies
June 08, 2022
Tickers
CMNDF
CYBN
EHVVF
NMLSF
Tags
News
CYBN
RVVTF
From
Benzinga
Nova Mentis NM-1001 Psilocybin Compound Gets DEA Approval For Export, Here's What Happened
June 07, 2022
Tickers
NMLSF
Tags
Market News
Cannabis
Penny Stocks
From
Benzinga
Nova Mentis Is Looking To Treat Autism With Psilocybin
April 07, 2022
Tickers
NMLSF
Tags
Market News
Cannabis
Penny Stocks
From
Benzinga
Psyched: Psilocybin Therapy Effective After One Year, Cybin & Deepak Chopra, Enveric Psilocybin Cancer Study
February 22, 2022
Tickers
CYBN
ENVB
FTRP
NMLSF
Tags
FTRP
Benzinga
Penny Stocks
From
Benzinga
This Psychedelics Penny Stock Is Up 55% After Successful Study On Microdosing For Autism
February 16, 2022
Tickers
NMLSF
Tags
Markets
Cannabis
Market News
From
Benzinga
Wellbeing Digital Sciences' Integrated Approach Aims To Capture Emerging Mental Health Tech And Psychedelics Market
February 08, 2022
Tickers
CGNSF
KONEF
NMLSF
Tags
Wellbeing Digital Sciences
Partner Content
KONEF
From
Benzinga
Wellbeing Digital Sciences' Subsidiary KGK Science Forms Tactical Partnership With Nova Mentis
January 27, 2022
Tickers
KONEF
NMLSF
Tags
Press Releases
Wellbeing Digital Sciences
Biotech
From
Benzinga
Psyched: Detroit Decriminalizes Psychedelics, Compass To Study Psilocybin For PTSD, Filaments Gets First-Ever FDA Approval
November 08, 2021
Tickers
CMPS
CYBN
FLHLF
NMLSF
Tags
Ian McDonald
Small Cap
Market News
From
Benzinga
Psyched: British PM Considers Psychedelics, New Partnership To Study Psilocybin For Autism, Compass Gets Another Patent
October 26, 2021
Tickers
AWKNF
CMPS
CYBN
DMTTF
Tags
Small Cap
Boris Johnson
AWKNF
From
Benzinga
Psyched: The 50 Publicly-listed Psychedelics Companies, Atai's New Subsidiary, PharmaTher Gets New Orphan Drug Designation
October 18, 2021
Tickers
AGNPF
ALID
ATAI
AWKNF
Tags
SILFF
WSNAF
Market News
From
Benzinga
There Are Now 50 Psychedelics Companies Listed In The U.S. - Here They Are
October 13, 2021
Tickers
AGNPF
ALID
ATAI
AWKNF
Tags
Penny Stocks
Benzinga
PSIL
From
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.